Comparing the efficacy of bevacizumab and ranibizumab in patients with retinal vein occlusion: the BRVO study, a randomized trial

Tunde Peto, Maartje J.C. Vader, A. nn-Sofie M.E. Schauwvlieghe, Frank D Verbraak, Greetje Dijkman, Johanna M.M. Hooymans, Leonoor I. Los, Aeilko H. Zwinderman, Tunde Peto, Carel B Hoyng, Redmer van Leeuwenhoek, Johannes R. Vingerling, Yvonne de Jong-Hesse, Janneke J.C. van Lith-Verhoeven, Marcel G.W. Dijkgraaf, Reinier O. Schlingemann

Research output: Contribution to journalArticle

Original languageEnglish
JournalOpthalmology Retina
Early online date07 Jan 2020
DOIs
Publication statusEarly online date - 07 Jan 2020

Cite this

Peto, T., Vader, M. J. C., Schauwvlieghe, A. N-S. M. E., Verbraak, F. D., Dijkman, G., Hooymans, J. M. M., Los, L. I., Zwinderman, A. H., Peto, T., Hoyng, C. B., Leeuwenhoek, R. V., Vingerling, J. R., Jong-Hesse, Y. D., Lith-Verhoeven, J. J. C. V., Dijkgraaf, M. G. W., & Schlingemann, R. O. (2020). Comparing the efficacy of bevacizumab and ranibizumab in patients with retinal vein occlusion: the BRVO study, a randomized trial. Opthalmology Retina. https://doi.org/10.1016/j.oret.2019.12.019